Total submissions: 2
            
    | Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment | 
|---|---|---|---|---|---|---|---|---|
| Evidence- | 
                        RCV000494757 | SCV000579013 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). | 
| Ambry Genetics | RCV000218449 | SCV000273588 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |